Phase-I Trial of Dose-Intense Liposome-Encapsulated Doxorubicin in Patients with Advanced Sarcoma
To define the maximum-tolerated dose (MTD) of liposome-encapsulated doxorubicin (LED) when used every 2 weeks with granulocyte colony-stimulating factor (G-CSF) in patients with advanced soft tissue sarcoma. Patients and Methods: Doxorubicin encapsulated in egg phosphatidylcholine/cholesterol liposo...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | text |
| Language: | English |
| Published: |
Institutional Knowledge at Singapore Management University
1997
|
| Subjects: | |
| Online Access: | https://ink.library.smu.edu.sg/soe_research/342 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Singapore Management University |
| Language: | English |